Brutman-Barazani T - Search Results

1

Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring.

Barg AA, Budnik I, Avishai E, Brutman-Barazani T, Bashari D, Misgav M, Lubetsky A, Kuperman AA, Livnat T, Kenet G. Barg AA, et al. Haemophilia. 2021 May;27(3):383-391. doi: 10.1111/hae.14318. Epub 2021 Apr 23. Haemophilia. 2021. PMID: 33892524

2

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.

Livnat T, Martinowitz U, Azar-Avivi S, Zivelin A, Brutman-Barazani T, Lubetsky A, Kenet G. Livnat T, et al. Haemophilia. 2013 Sep;19(5):782-9. doi: 10.1111/hae.12181. Epub 2013 May 10. Haemophilia. 2013. PMID: 23659442 Clinical Trial.

3

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.

Misgav M, Lubetszki A, Brutman-Barazani T, Martinowitz U, Kenet G. Misgav M, et al. J Vasc Access. 2017 May 15;18(3):220-224. doi: 10.5301/jva.5000707. Epub 2017 Apr 28. J Vasc Access. 2017. PMID: 28478622

4

Combination of hemostatic therapies for treatment of patients with hemophilia A and inhibitors.

Livnat T, Budnik I, Levy-Mendelovich S, Avishai E, Misgav M, Barg AA, Lubetsky A, Brutman-Barazani T, Kenet G. Livnat T, et al. Blood Cells Mol Dis. 2017 Jul;66:1-5. doi: 10.1016/j.bcmd.2017.06.005. Epub 2017 Jun 27. Blood Cells Mol Dis. 2017. PMID: 28689155

5

[HEMOPHILIA - A ROYAL DISEASE IN THE HOLY LAND].

Barg AA, Dardik R, Levy-Mendelovich S, Brutman Barazani T, Bashari D, Kenet G. Barg AA, et al. Harefuah. 2019 Mar;158(3):173-175. Harefuah. 2019. PMID: 30916504 Hebrew.

6

Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions.

Levy-Mendelovich S, Livnat T, Barg AA, Kidon M, Brutman-Barazani T, Kenet G. Levy-Mendelovich S, et al. Blood Cells Mol Dis. 2020 Feb;80:102370. doi: 10.1016/j.bcmd.2019.102370. Epub 2019 Oct 20. Blood Cells Mol Dis. 2020. PMID: 31669933

7

Emicizumab treatment and monitoring in a paediatric cohort: real-world data.

Barg AA, Livnat T, Budnik I, Avishai E, Brutman-Barazani T, Tamarin I, Bashari D, Misgav M, Kenet G. Barg AA, et al. Br J Haematol. 2020 Oct;191(2):282-290. doi: 10.1111/bjh.16964. Epub 2020 Jul 12. Br J Haematol. 2020. PMID: 32656767 Free article.

8

Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data.

Misgav M, Brutman-Barazani T, Budnik I, Avishai E, Schapiro J, Bashari D, Barg AA, Lubetsky A, Livnat T, Kenet G. Misgav M, et al. Haemophilia. 2021 Mar;27(2):253-260. doi: 10.1111/hae.14261. Epub 2021 Feb 17. Haemophilia. 2021. PMID: 33595174

9

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab.

Levy-Mendelovich S, Brutman-Barazani T, Budnik I, Avishai E, Barg AA, Levy T, Misgav M, Livnat T, Kenet G. Levy-Mendelovich S, et al. J Clin Med. 2021 Sep 22;10(19):4303. doi: 10.3390/jcm10194303. J Clin Med. 2021. PMID: 34640320 Free PMC article.

10

Pediatric severe factor XI deficiency: A multicenter study.

Barg AA, Levy-Mendelovich S, Budnik I, Mandel-Shorer N, Dardik R, Avishai E, Brutman-Barazani T, Ifrah AD, Oren-Malek L, Yacobovich J, Gilad O, Nakav S, Fruchtman Y, Revel-Vilk S, Miskin H, Kenet G. Barg AA, et al. Pediatr Blood Cancer. 2022 Mar;69(3):e29545. doi: 10.1002/pbc.29545. Epub 2021 Dec 26. Pediatr Blood Cancer. 2022. PMID: 34957695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters